Country: United States
Language: English
Source: NLM (National Library of Medicine)
ZONISAMIDE (UNII: 459384H98V) (ZONISAMIDE - UNII:459384H98V)
Zydus Lifesciences Limited
ZONISAMIDE
ZONISAMIDE 25 mg
ORAL
PRESCRIPTION DRUG
Zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. Zonisamide capsules are contraindicated in patients who have demonstrated hypersensitivity to sulfonamides or zonisamide. The abuse and dependence potential of zonisamide has not been evaluated in human studies (see WARNINGS, Cognitive/Neuropsychiatric Adverse Events subsection ). In a series of animal studies, zonisamide did not demonstrate abuse liability and dependence potential. Monkeys did not self-administer zonisamide in a standard reinforcing paradigm. Rats exposed to zonisamide did not exhibit signs of physical dependence of the CNS-depressant type. Rats did not generalize the effects of diazepam to zonisamide in a standard discrimination paradigm after training, suggesting that zonisamide does not have abuse potential of the benzodiazepine-CNS depressant type.
Zonisamide capsules, 25 mg are white to off white granular powder filled in size '4' hard gelatin capsules with pink colored cap printed with "ZA-31" in black ink and white colored body printed with "25 mg" in black ink, which are supplied as follows. NDC 70771-1142-1 in bottles of 100's capsules NDC 70771-1142-5 in bottles of 500's capsules Zonisamide capsules, 50 mg are white to off white granular powder filled in size '3' hard gelatin capsules with pink colored cap printed with "ZA-32" in black ink and white colored body printed with "50 mg" in black ink, which are supplied as follows. NDC 70771-1143-1 in bottles of 100's capsules NDC 70771-1143-5 in bottles of 500's capsules Zonisamide capsules, 100 mg are white to off white granular powder filled in size '1' hard gelatin capsules with pink colored cap printed with "ZA-33" in black ink and white colored body printed with "100 mg" in black ink, which are supplied as follows. NDC 70771-1144-1 in bottles of 100's capsules NDC 70771-1144-5 in bottles of 500's capsules NDC 70771-1144-0 in bottles of 1000's capsules Store at 20o – 25o C (68o – 77o F) [see USP Controlled Room Temperature]. Keep in dry place and protect from light. Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. Rev.: 11/17
Abbreviated New Drug Application
Zydus Lifesciences Limited ---------- Manufactured by: Cadila Healthcare Ltd. India SPL MEDGUIDE Revised: 10/2023 Document Id: c4382248-d7f2-4082-8ee9-dc4bf53779f7 34391-3 Set id: 4a4de4ca-6e4a-4b62-b2b4-26cef6dafb2f Version: 7 Effective Time: 20231004 Zydus Lifesciences Limited Read the complete document
ZONISAMIDE- ZONISAMIDE CAPSULE ZYDUS LIFESCIENCES LIMITED ---------- ZONISAMIDE CAPSULES MANUFACTURED BY: Cadila Healthcare Ltd. India SPL MEDGUIDE PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1142-1 in bottle of 100 Capsules Zonisamide Capsules, 25 mg R only 100 Capsules NDC 70771-1143-1 in bottle of 100 Capsules Zonisamide Capsules, 50 mg x R only 100 Capsules NDC 70771-1144-1 in bottle of 100 Capsules Zonisamide Capsules, 100 mg R only 100 Capsules x x ZONISAMIDE zonisamide capsule PRODUCT INFORMATION PRODUCT TYPE HUMAN PRESCRIPTION DRUG ITEM CODE (SOURCE) NDC:70771-1142 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH ZONISAMIDE (UNII: 459384H98V) (ZONISAMIDE - UNII:459384H98V) Z ONISAMIDE 25 mg INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH FD&C BLUE NO. 1 (UNII: H3R47K3TBD) FD&C RED NO. 4 (UNII: X3W0AM1JLX) GELATIN (UNII: 2G86QN327L) HYDROGENATED COTTONSEED OIL (UNII: Z82Y2C65EA) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) SODIUM LAURYL SULFATE (UNII: 368GB5141J) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) PRODUCT CHARACTERISTICS COLOR PINK (PINK) , WHITE (WHITE) SCORE no score SHAPE CAPSULE (CAPSULE) SIZE 14mm FLAVOR IMPRINT CODE Z A;31;25;mg CONTAINS PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:70771- 1142-1 100 in 1 BOTTLE; Type 0: Not a Combination Product 11/22/2017 2 NDC:70771- 1142-5 500 in 1 BOTTLE; Type 0: Not a Combination Product 11/22/2017 MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE ANDA ANDA077625 11/22/2017 ZONISAMIDE zonisamide capsule PRODUCT INFORMATION PRODUCT TYPE HUMAN PRESCRIPTION DRUG ITEM CODE (SOURCE) NDC:70771-1143 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH ZONISAMIDE (UNII: 459384H98V) (ZONISAMIDE - UNII:459384H98V) Z ONISAMIDE 50 mg INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH FD&C BLUE NO. 1 (UNII: H3R47K3TBD) FD&C RED NO. 4 (UNII: X3W0AM1JLX) GELAT Read the complete document